New monoclonal antibody shows promise for severe asthma
Study: Importance of harm and abuse education for primary school children
28 October 2021New research casts doubt on claims that people have ‘rose-tinted glasses’
28 October 2021New monoclonal antibody shows promise for severe asthma
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
